Alpelisib
( DrugBank: Alpelisib / KEGG DRUG: Alpelisib )
4 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 138 | Nerve cell migration disorder | 1 |
| 278 | Huge lymphatic malformation with cervicofacial lesion | 3 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 279 | Huge venous malformation with cervical, oral and pharyngeal diffuse lesion | 1 |
| 280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 1 |
138. Nerve cell migration disorder
Clinical trials : 2 / Drugs : 4 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 106
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
278. Huge lymphatic malformation with cervicofacial lesion
Clinical trials : 47 / Drugs : 48 - (DrugBank : 15) / Drug target genes : 8 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
Clinical trials : 28 / Drugs : 36 - (DrugBank : 15) / Drug target genes : 6 - Drug target pathways : 138
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
280. Huge arteriovenous malformation with cervicofacial or limb lesion
Clinical trials : 36 / Drugs : 41 - (DrugBank : 17) / Drug target genes : 12 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
